| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $479.6M | — | -1.1% |
| Cost of Revenue | $394.7M | — | -4.2% |
| Gross Profit | $84.9M | — | +16.9% |
| R&D Expense | $5.5M | — | -12.7% |
| SG&A Expense | $54.8M | — | -13.4% |
| Operating Income | $7.3M | — | +101.7% |
| Pre-tax Income | -$8.7M | — | +98.1% |
| Income Tax | $3.0M | — | +112.1% |
| Net Income | -$11.7M | — | +97.3% |
| EPS (Basic) | -$0.22 | — | +97.2% |
| EPS (Diluted) | -$0.22 | — | +97.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $82.3M | -2.3% | -2.0% |
| Accounts Receivable | $202.8M | +12.1% | +0.3% |
| Inventory | $334.7M | +1.7% | -3.3% |
| Current Assets | $664.9M | +4.1% | -3.1% |
| Total Assets | $2.03B | -0.8% | -0.9% |
| Current Liabilities | $294.1M | +3.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $1.0M | — | +106.3% |
| Capital Expenditures | $8.4M | — | -39.6% |
| Investing Cash Flow | -$8.4M | — | +20.8% |
| Financing Cash Flow | $5.9M | — | -75.9% |
| Free Cash Flow | -$7.4M | — | +75.2% |
| +2.1% |
| Long-term Debt | $1.05B | +1.5% | -8.3% |
| Total Liabilities | $1.56B | +0.6% | -3.8% |
| Stockholders' Equity | $472.3M | -5.3% | +10.3% |